Inventor · disambiguated record
Patrick Gosselin
Also filed as: GOSSELIN PATRICK
23 granted patents·5 pending applications·77 citations·filing 1997–2024
95Inventor score
Files withREDHILL BIOPHARMA LTD14RED HILL BIOPHARMA LTD4EIGER BIOPHARMACEUTICALS INC3BAUSCH HEALTH COMPANIES INC2CILAS1
Top patents by PatentIndex Score
28 records- 0194US11517532B2Methods of treating hepatitis delta virus infectionEIGER BIOPHARMACEUTICALS INC·Filed 2020·Granted Dec 6, 2022·3 cites·23 claims
- 0294US10238606B2Pharmaceutical compositions for the treatment of Helicobacter pyloriREDHILL BIOPHARMA LTD·Filed 2017·Granted Mar 26, 2019·6 cites·6 claims
- 0393US12029819B2Pharmaceutical compositions comprising lonafarnib and ritonavirEIGER BIOPHARMACEUTICALS INC·Filed 2022·Granted Jul 9, 2024·1 cites·20 claims
- 0493US9603806B2Pharmaceutical compositions for the treatment of Helicobacter pyloriREDHILL BIOPHARMA LTD·Filed 2016·Granted Mar 28, 2017·5 cites·20 claims
- 0593US9498445B2Pharmaceutical compositions for the treatment of Helicobacter pyloriREDHILL BIOPHARMA LTD·Filed 2014·Granted Nov 22, 2016·7 cites·18 claims
- 0690US11135172B2Rifabutin-based compositions and methods for treating Helicobacter pylori infectionREDHILL BIOPHARMA LTD·Filed 2019·Granted Oct 5, 2021·2 cites·13 claims
- 0788US2024325313A1Pharmaceutical compositions for the treatment of helicobacter pyloriREDHILL BIOPHARMA LTD·Filed 2024·Application pending·0 cites
- 0887US9050263B2Pharmaceutical compositions for the treatment of Helicobacter pyloriFATHI REZA·Filed 2014·Granted Jun 9, 2015·11 cites·24 claims
- 0986US10434114B2Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibioticsREDHILL BIOPHARMA LTD·Filed 2018·Granted Oct 8, 2019·2 cites·11 claims
- 1085US10835496B2Pharmaceutical compositions comprising lonafarnib and ritonavirEIGER BIOPHARMACEUTICALS INC·Filed 2016·Granted Nov 17, 2020·4 cites·24 claims
- 1185US8343511B2Methods and compositions for treating inflammatory bowel diseaseRED HILL BIOPHARMA LTD·Filed 2009·Granted Jan 1, 2013·4 cites·5 claims
- 1282US8460640B2Narcotic drug formulations with decreased abuse potentialVINSON ROBERT·Filed 2009·Granted Jun 11, 2013·14 cites·28 claims
- 1381US10765691B2Method for treating crohn's disease using triple antimicrobial all-in-one formulationREDHILL BIOPHARMA LTD·Filed 2019·Granted Sep 8, 2020·0 cites·3 claims
- 1480US11931463B2All-in-one fixed-dose combination for treating Helicobacter pylori infectionREDHILL BIOPHARMA LTD·Filed 2021·Granted Mar 19, 2024·0 cites·15 claims
- 1580US9198926B2Methods and compositions comprising rifabutin, clarithromycin, and clofazimineRED HILL BIOPHARMA LTD·Filed 2014·Granted Dec 1, 2015·2 cites·16 claims
- 1677US10898439B2Methods for treating helicobacter pylori infectionREDHILL BIOPHARMA LTD·Filed 2019·Granted Jan 26, 2021·0 cites·20 claims
- 1774US11090326B2Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimineREDHILL BIOPHARMA LTD·Filed 2020·Granted Aug 17, 2021·0 cites·16 claims
- 1872US10813898B2Solid dosage forms of vigabatrinORPHELIA PHARMA·Filed 2016·Granted Oct 27, 2020·2 cites·14 claims
- 1970US10143702B2Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimineREDHILL BIOPHARMA LTD·Filed 2018·Granted Dec 4, 2018·0 cites·5 claims
- 2068US10105379B2Pharmaceutical compositions comprising three antibioticsREDHILL BIOPHARMA LTD·Filed 2017·Granted Oct 23, 2018·0 cites·6 claims
- 2168US9314477B2Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereofRED HILL BIOPHARMA LTD·Filed 2014·Granted Apr 19, 2016·0 cites·11 claims
- 2265US9072763B2Methods and compositions for treating inflammatory bowel diseaseRED HILL BIOPHARMA LTD·Filed 2012·Granted Jul 7, 2015·0 cites·20 claims
- 2363US2016228464A1Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereofREDHILL BIOPHARMA LTD·Filed 2016·Application pending·0 cites
- 2457US2018028452A1Antiemetic extended release solid dosage formsREDHILL BIOPHARMA LTD·Filed 2017·Application pending·0 cites
- 2557US2023241102A1Formulations of calcium and phosphate for oral inflammationBAUSCH HEALTH COMPANIES INC·Filed 2023·Application pending·0 cites
- 2650US2023174493A1Solid Dispersions of Amorphous 3,4-Diphenyl-4,5-Dihydro-1H-Pyrazole Derivatives, Compositions Comprising them and Uses Thereof as Cannabinoid CB1 Receptor InhibitorsINVERSAGO PHARMA INC·Filed 2021·Application pending·0 cites
- 2744US11590165B2Formulations of calcium and phosphate for oral inflammationBAUSCH HEALTH COMPANIES INC·Filed 2015·Granted Feb 28, 2023·0 cites·10 claims
- 2844US6023057ADevice for determining the phase errors of electromagnetic wavesCILAS·Filed 1997·Granted Feb 8, 2000·14 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Patrick Gosselin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →